Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Breast (Edinburgh, Scotland)
|
May 3, 2011
Leiomyosarcoma of the breast: a case report and review of the literature about therapeutic management
Noriko Fujita, Ryo Kimura, Jun Yamamura, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 19, 2002
Overview: video-assisted breast surgery
Yasuhiro Tamaki, Fumine Tsukamoto, Yasuo Miyoshi, et al.
Annals of Surgical Oncology
|
February 13, 2008
Intraoperative frozen section analysis of sentinel lymph node in breast cancer patients treated with neoadjuvant chemotherapy
Kenzo Shimazu, Yasuhiro Tamaki, Tetsuya Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 1, 2003
[A case of metastatic pheochromocytoma with remarkable response to combination of cyclophosphamide, vincristine and dacarbazine]
Yasuto Naoi, Yasuhiro Tamaki, Masaru Ooka, et al.
Anticancer Research
|
May 23, 2002
uPA receptor expression in benign and malignant thyroid tumors
Seung Jin Kim, Eiichi Shiba, Tetsuya Taguchi, et al.
Breast Cancer Research and Treatment
|
June 2, 2011
A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients
Seung Jin Kim, Akinori Masago, Yasuhiro Tamaki, et al.
BMC Cancer
|
October 6, 2021
Multicenter retrospective study on the use of Curebest™ 95GC Breast for estrogen receptor-positive and node-negative early breast cancer
Fumine Tsukamoto, Koji Arihiro, Mina Takahashi, et al.
Cancer Letters
|
September 15, 2014
The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapy
Seung Jin Kim, Norikazu Masuda, Fumine Tsukamoto, et al.
Oncology
|
July 8, 2010
Phase II trial in Japan of sequential administration of weekly paclitaxel followed by FEC as neoadjuvant chemotherapy for locally advanced breast cancer [KBCSG0206 trial: Kinki Breast Cancer Study Group (KBCSG)]
Tetsuya Taguchi, Norikazu Masuda, Takahiro Nakayama, et al.
Breast Cancer Research and Treatment
|
August 20, 2009
Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group
Kenichi Inoue, Kazuhiko Nakagami, Mitsuhiro Mizutani, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Breast (Edinburgh, Scotland)
|
May 3, 2011
Leiomyosarcoma of the breast: a case report and review of the literature about therapeutic management
Noriko Fujita, Ryo Kimura, Jun Yamamura, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 19, 2002
Overview: video-assisted breast surgery
Yasuhiro Tamaki, Fumine Tsukamoto, Yasuo Miyoshi, et al.
Annals of Surgical Oncology
|
February 13, 2008
Intraoperative frozen section analysis of sentinel lymph node in breast cancer patients treated with neoadjuvant chemotherapy
Kenzo Shimazu, Yasuhiro Tamaki, Tetsuya Taguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 1, 2003
[A case of metastatic pheochromocytoma with remarkable response to combination of cyclophosphamide, vincristine and dacarbazine]
Yasuto Naoi, Yasuhiro Tamaki, Masaru Ooka, et al.
Anticancer Research
|
May 23, 2002
uPA receptor expression in benign and malignant thyroid tumors
Seung Jin Kim, Eiichi Shiba, Tetsuya Taguchi, et al.
Breast Cancer Research and Treatment
|
June 2, 2011
A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients
Seung Jin Kim, Akinori Masago, Yasuhiro Tamaki, et al.
BMC Cancer
|
October 6, 2021
Multicenter retrospective study on the use of Curebest™ 95GC Breast for estrogen receptor-positive and node-negative early breast cancer
Fumine Tsukamoto, Koji Arihiro, Mina Takahashi, et al.
Cancer Letters
|
September 15, 2014
The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapy
Seung Jin Kim, Norikazu Masuda, Fumine Tsukamoto, et al.
Oncology
|
July 8, 2010
Phase II trial in Japan of sequential administration of weekly paclitaxel followed by FEC as neoadjuvant chemotherapy for locally advanced breast cancer [KBCSG0206 trial: Kinki Breast Cancer Study Group (KBCSG)]
Tetsuya Taguchi, Norikazu Masuda, Takahiro Nakayama, et al.
Breast Cancer Research and Treatment
|
August 20, 2009
Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group
Kenichi Inoue, Kazuhiko Nakagami, Mitsuhiro Mizutani, et al.
Page
of 2